NASDAQ:HUMAW
Humacyte, Inc.
- Stock
Last Close
6.47
16/05 20:00
Market Cap
301.40M
Beta: -
Volume Today
4.32M
Avg: -
PE Ratio
−3.64
PFCF: −4.65
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
net income | -85.42M - | -66.52M 22.12% | -26.48M 60.20% | -11.96M 54.81% | -110.78M 825.83% | |
depreciation and amortization | 6.75M - | 8.35M 23.74% | 8.24M 1.32% | 8.21M 0.38% | 5.66M 31.07% | |
deferred income tax | -4.27M - | 177K 104.14% | -17.80M 10,157.06% | -173K 99.03% | ||
stock based compensation | 4.46M - | 4.69M 5.32% | 10.15M 116.15% | 6.18M 39.05% | 6.83M 10.41% | |
change in working capital | -185K - | -2.37M 1,180.54% | -557K 76.49% | 1.03M 284.74% | 4.84M 370.55% | |
accounts receivables | -185K - | 488K 363.78% | -63K 112.91% | 145K 330.16% | 31K 78.62% | |
inventory | -2.26M - | -181K 91.98% | ||||
accounts payables | 2.43M - | -889K 136.52% | -197K 77.84% | -509K 158.38% | 4.81M 1,045.19% | |
other working capital | -2.25M - | 289K 112.85% | -116K 140.14% | 1.39M 1,300.86% | -4.84M 447.60% | |
other non cash items | 6.89M - | 103K 98.50% | -54.74M 53,247.57% | -74.41M 35.94% | 24.98M 133.57% | |
net cash provided by operating activities | -71.79M - | -55.57M 22.59% | -81.19M 46.11% | -71.13M 12.39% | -73.31M 3.06% | |
investments in property plant and equipment | -8.13M - | -318K 96.09% | -220K 30.82% | -1.05M 376.36% | -2.28M 117.56% | |
acquisitions net | 50K - | -5.89M - | ||||
purchases of investments | -8M - | -10.11M 26.34% | ||||
sales maturities of investments | 16M - | 2.11M 86.83% | ||||
other investing activites | 5.89M - | |||||
net cash used for investing activites | -8.13M - | -268K 96.70% | -8.22M 2,967.16% | 4.84M 158.94% | -173K 103.57% | |
debt repayment | -1.29M - | -1.50M 16.10% | -1.73M 15.27% | -1.98M 14.57% | -2.26M 13.88% | |
common stock issued | 301K - | 598K 98.67% | 535K 10.54% | |||
common stock repurchased | ||||||
dividends paid | ||||||
other financing activites | -74K - | 3.25M 4,493.24% | 268.11M 8,147.12% | 6.76M - | ||
net cash used provided by financing activities | -74K - | 2.05M 2,872.97% | 266.98M 12,910.87% | -1.45M 100.54% | 4.51M 411.69% | |
effect of forex changes on cash | 173.70M - | |||||
net change in cash | -79.99M - | -53.78M 32.76% | 177.57M 430.16% | -67.73M 138.14% | -68.97M 1.83% | |
cash at beginning of period | 173.70M - | 93.71M 46.05% | 39.93M 57.39% | 217.50M 444.72% | 149.77M 31.14% | |
cash at end of period | 93.71M - | 39.93M 57.39% | 217.50M 444.72% | 149.77M 31.14% | 80.80M 46.05% | |
operating cash flow | -71.79M - | -55.57M 22.59% | -81.19M 46.11% | -71.13M 12.39% | -73.31M 3.06% | |
capital expenditure | -8.13M - | -318K 96.09% | -220K 30.82% | -1.05M 376.36% | -2.28M 117.56% | |
free cash flow | -79.91M - | -55.89M 30.07% | -81.41M 45.67% | -72.18M 11.34% | -75.58M 4.72% |
All numbers in USD (except ratios and percentages)